Harpreet S. Dhaliwal - Nov 8, 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Cml Mfg & Supply Chain
Signature
Harpreet S. Dhaliwal, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Nov 8, 2021
Transactions value $
$0
Form type
4
Date filed
2/1/2022, 04:41 PM
Previous filing
Oct 6, 2021
Next filing
Mar 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (Right to Buy) Award $0 +100K $0.00 100K Nov 8, 2021 Common Stock 100K $25.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option shall vest on October 1, 2022, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date